Community Bank N.A. decreased its position in UnitedHealth Group Inc (NYSE:UNH) by 10.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 7,560 shares of the healthcare conglomerate’s stock after selling 900 shares during the period. Community Bank N.A.’s holdings in UnitedHealth Group were worth $1,481,000 at the end of the most recent quarter.
A number of other hedge funds have also recently added to or reduced their stakes in the stock. Longview Partners Guernsey LTD lifted its holdings in UnitedHealth Group by 4.8% in the third quarter. Longview Partners Guernsey LTD now owns 4,724,845 shares of the healthcare conglomerate’s stock valued at $925,361,000 after buying an additional 214,300 shares during the period. Ironwood Investment Counsel LLC acquired a new position in UnitedHealth Group in the third quarter valued at $328,000. Heritage Investors Management Corp lifted its holdings in UnitedHealth Group by 8.5% in the third quarter. Heritage Investors Management Corp now owns 21,185 shares of the healthcare conglomerate’s stock valued at $4,149,000 after buying an additional 1,668 shares during the period. Bainco International Investors lifted its holdings in UnitedHealth Group by 5.4% in the third quarter. Bainco International Investors now owns 82,676 shares of the healthcare conglomerate’s stock valued at $16,192,000 after buying an additional 4,202 shares during the period. Finally, Cable Hill Partners LLC lifted its holdings in UnitedHealth Group by 337.4% in the third quarter. Cable Hill Partners LLC now owns 1,894 shares of the healthcare conglomerate’s stock valued at $371,000 after buying an additional 1,461 shares during the period. Institutional investors and hedge funds own 86.01% of the company’s stock.
In other UnitedHealth Group news, Director Kenneth Irwin Shine sold 457 shares of the company’s stock in a transaction dated Tuesday, November 14th. The shares were sold at an average price of $211.03, for a total value of $96,440.71. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Larry C. Renfro sold 22,598 shares of the company’s stock in a transaction dated Friday, December 15th. The stock was sold at an average price of $221.75, for a total transaction of $5,011,106.50. Following the completion of the sale, the chief executive officer now directly owns 195,314 shares of the company’s stock, valued at $43,310,879.50. The disclosure for this sale can be found here. Insiders sold a total of 34,630 shares of company stock valued at $7,669,416 over the last ninety days. 0.89% of the stock is currently owned by insiders.
Shares of UnitedHealth Group Inc (UNH) opened at $228.64 on Friday. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.70 and a quick ratio of 0.70. UnitedHealth Group Inc has a fifty-two week low of $156.09 and a fifty-two week high of $231.77. The firm has a market cap of $221,060.00, a PE ratio of 25.98, a P/E/G ratio of 1.57 and a beta of 0.66.
UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The company had revenue of $50.32 billion for the quarter, compared to analyst estimates of $50.38 billion. During the same quarter in the prior year, the business posted $2.17 EPS. The firm’s revenue was up 8.7% compared to the same quarter last year. analysts expect that UnitedHealth Group Inc will post 9.99 earnings per share for the current fiscal year.
UNH has been the topic of several recent analyst reports. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 target price on the stock in a report on Thursday, September 21st. ValuEngine lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 5th. Sanford C. Bernstein reiterated an “outperform” rating and set a $210.00 price objective on shares of UnitedHealth Group in a report on Tuesday, October 10th. Jefferies Group upped their price objective on shares of UnitedHealth Group from $215.00 to $225.00 and gave the company a “buy” rating in a report on Friday, October 13th. Finally, BMO Capital Markets initiated coverage on shares of UnitedHealth Group in a report on Monday, October 16th. They set an “outperform” rating and a $250.00 price objective on the stock. Three research analysts have rated the stock with a hold rating and twenty-five have given a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $229.54.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.